Obicetrapib as a cholesteryl ester transfer protein inhibitor: a clinical and pharmacological review and prospects for use (literature review)
| dc.contributor.author | Dunaieva, Inna | |
| dc.contributor.author | Kryvoshapka, Oleksandr | |
| dc.contributor.author | Pautina, Olena | |
| dc.contributor.author | Doroshenko, Oksana | |
| dc.contributor.author | Shapoval, Olga | |
| dc.contributor.author | Chorna, Natalia | |
| dc.contributor.author | Ruda, Natalia | |
| dc.date.accessioned | 2026-03-30T10:03:45Z | |
| dc.date.issued | 2026 | |
| dc.identifier.citation | Obicetrapib as a cholesteryl ester transfer protein inhibitor: a clinical and pharmacological review and prospects for use (literature review) / I. P. Dunaieva, O. V. Kryvoshapka, O. I. Pautina, O. M. Doroshenko, O. M. Shapoval, N. S. Chorna, N. G. Ruda // Bulletin of problems in biology and medicine. – 2026. – Issue 1 (180). – P. 61─71. ─ DOI: 10.29254/2077-4214-2026-1-180-61-72. | |
| dc.identifier.issn | ISSN 2077-4214 | |
| dc.identifier.issn | E–ISSN 2523–4110 | |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/37877 | |
| dc.language.iso | en | |
| dc.subject | obicetrapib | |
| dc.subject | cholesteryl ester transfer protein | |
| dc.subject | dyslipidemia | |
| dc.subject | lipid-lowering therapy | |
| dc.subject | cardiovascular risk. | |
| dc.subject | 2026а | |
| dc.title | Obicetrapib as a cholesteryl ester transfer protein inhibitor: a clinical and pharmacological review and prospects for use (literature review) | |
| dc.type | Article |